Home › Prostate Cancer › NCT07093177
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
Who can join
Ages 18 and older · Men
Full eligibility criteria
Inclusion Criteria: * Age 18 and older * Confirmed diagnosis of prostate cancer * Men receiving standard-of-care ADT either for high-risk, locally advanced prostate cancer or as a part of multicomponent management of metastatic prostate cancer * Residing in a rural community, as indicated by zip code in RUCA areas Exclusion Criteria: * Unstable angina, uncontrolled hypertension, recent myocardial infarction, pacemakers, painful or unstable bony metastases, or recent skeletal fractures * Engaged in a regular exercise rehabilitation program * Relocation plans within next 3 months * Participating in another clinical trial * Have a working telephone line in their home or a cell phone.
About the study
Prostate cancer has a significant impact on patient quality of life (QoL) directly, as well as through the management of localized disease (such as surgery and radiation-related incontinence, erectile dysfunction, and bowel dysfunction), and via direct side effects of androgen deprivation therapy (ADT) resulting in a considerable physical and psychological burden. Recent studies demonstrated the efficacy of multimodal rehabilitation for functional recovery, improvements in QoL, reduction in cancer symptoms, and secondary and tertiary prevention. Despite the mounting evidence regarding the benefits of multimodal rehabilitation for this population, multiple barriers limit the access of prostate cancer survivors to cancer rehabilitation, especially in rural areas.
This study is a pilot study to assess usability, acceptability, and exercise adherence in 12-week multimodal telerehabilitation in patients receiving ADT with either high-risk or metastatic prostate cancer residing in rural areas.
What is being tested
- Telerehabilitation Unit (behavioral)
Sponsor: University of Utah · Participants: 30 · Started: Feb 24, 2026
Contact the study team
- Manish Kohli, MD · Phone: 801-646-4018
Official record on ClinicalTrials.gov — NCT07093177
Locations in the U.S.
| Utah | Huntsman Cancer Institute at University of Utah, Salt Lake City |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.